Alexander Josowitz is a Principal Scientist at Regeneron, specializing in drug product development and technology. Prior to this role, they served as a Senior Scientist in Formulations Development at Regeneron from 2022 to 2026. Alexander earned a PhD in biomedical engineering from Yale University, where their research focused on polymeric nanoparticle drug delivery systems, particularly for chemotherapy and COVID-19 treatment. They also have experience as a student researcher at various institutions and internships at Alnylam Pharmaceuticals, contributing to advancements in drug synthesis and delivery methodologies. Alexander holds multiple degrees in bioengineering and biomedical engineering from the University of Pittsburgh and Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices